Literature DB >> 23537910

Stop routine CD4 monitoring in HIV-infected patients with fully suppressed virus and CD4 >=350 cells/ml.

G G Whitlock, N Ahmed, P Benn, S Edwards, L Waters.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23537910     DOI： 10.1093/cid/cit203

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.

Authors:  Jin Young Ahn; David Boettiger; Matthew Law; Nagalingeswaran Kumarasamy; Evy Yunihastuti; Romanee Chaiwarith; Man Po Lee; Benedict L H Sim; Shinichi Oka; Wingwai Wong; Adeeba Kamarulzaman; Pacharee Kantipong; Praphan Phanuphak; Oon Tek Ng; Sasisopin Kiertiburanakul; Fujie Zhang; Sanjay Pujari; Rossana Ditangco; Winai Ratanasuwan; Tuti Parwati Merati; Vonthanak Saphonn; Annette H Sohn; Jun Yong Choi
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

2.  A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey.

Authors:  Jonathan M Kagan; Ana M Sanchez; Alan Landay; Thomas N Denny
Journal:  For Immunopathol Dis Therap       Date:  2015

3.  Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression.

Authors:  Mary-Ann Davies; Nathan Ford; Helena Rabie; Geoffrey Fatti; Kathryn Stinson; Janet Giddy; Frank Tanser; Karl-Günter Technau; Shobna Sawry; Brian Eley; Robin Wood; Lynne M Mofenson; Olivia Keiser; Andrew Boulle
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

4.  Monitoring of HIV treatment in seven countries in the WHO Region of the Americas.

Authors:  Pablo F Belaunzarán-Zamudio; Yanink N Caro-Vega; Bryan E Shepherd; Brenda E Crabtree-Ramírez; Paula M Luz; Beatriz Grinsztejn; Carina Cesar; Pedro Cahn; Claudia Cortés; Marcelo Wolff; Jean W Pape; Denis Padgett; Eduardo Gotuzzo; Catherine McGowan; Juan G Sierra-Madero
Journal:  Bull World Health Organ       Date:  2015-05-27       Impact factor: 9.408

5.  A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis?

Authors:  Ravindra K Gupta; Michael Marks; Simon G Edwards; Katie Smith; Katie Fletcher; Siow-Ming Lee; Alan Ramsay; Andrew J Copas; Robert F Miller
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?

Authors:  Antonio Di Biagio; Marta Ameri; Davide Sirello; Giovanni Cenderello; Enrico Di Bella; Lucia Taramasso; Barbara Giannini; Mauro Giacomini; Claudio Viscoli; Giovanni Cassola; Marcello Montefiori
Journal:  BMC Infect Dis       Date:  2017-02-06       Impact factor: 3.090

Review 7.  CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis.

Authors:  Nathan Ford; Kathryn Stinson; Howard Gale; Edward J Mills; Wendy Stevens; Mercedes Pérez González; Mercedes P González; Jessica Markby; Andrew Hill
Journal:  J Int AIDS Soc       Date:  2015-08-07       Impact factor: 5.396

8.  Derivation and validation of an accurate estimation of CD4 counts from the absolute lymphocyte count in virologically suppressed and immunologically reconstituted HIV infected adults.

Authors:  Barnaby Young; Oon Tek Ng; David Chien Lye; Yee Sin Leo
Journal:  BMC Infect Dis       Date:  2015-08-13       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.